A UCL study found that 70% of young people with long Covid recovered within 24 months, but recovery was less likely among older teenagers, females, and those from deprived backgrounds. Researchers emphasized the need for further investigation and collaboration to address unresolved cases.
A new study led by UCL researchers reveals that most young individuals diagnosed with long Covid three months after a positive PCR test had fully recovered within 24 months.
The Children and young people with Long Covid (CLoCK) study, published in Nature Communications Medicine and funded by the National Institute for Health and Care Research (NIHR), is the world's largest longitudinal cohort study on long Covid in children.
The researchers, led by Professor Sir Terence Stephenson and Professor Roz Shafran (both UCL Great Ormond Street Institute of Child Health), asked young people aged 11 to 17 about their health three, six, 12 and 24 months after taking a PCR test for the Covid virus between September 2020 and March 2021. They also asked them to recall their symptoms at the time of taking the test.
In February 2022, the researchers published a consensus definition of long Covid which involved a young person having more than one symptom (such as tiredness, trouble sleeping, shortness of breath or headaches) alongside problems with either mobility, self-care, doing usual activities, having pain/discomfort, or feeling very worried or sad.
The researchers used this definition for their new study, which examined data from 12,632 young people who had a PCR test for SARS-CoV-2 (the virus that causes COVID-19). They found that around 25-30% of young people met the research definition of long Covid 24 months after their initial PCR test.
Study Results: Recovery Trends
Of the 12,632 young people in total, there were 943 who had tested positive when first approached and who provided answers at every time point: three, six, 12 and 24 months after their original test.
Of these 943 young people, 233 met the research definition of long Covid three months after their initial positive test. At six months,135 continued to meet the research definition of long Covid. At 12 months, 94 continued to fulfill the long Covid research definition.
However, only 68 of these 943 children and young people (7.2%) continued to fulfill the long Covid research definition when contacted 24 months after their initial positive test.
This means that 24 months after a proven Covid infection, 165 of the 233 young people (70%) who had long Covid three months after the infection and provided information at every time point in the research had recovered. But 68 of the 233 (30%) had not.
Key Demographic Findings
Older teenagers and the most deprived were less likely to have recovered. And, strikingly, females were almost twice as likely to still meet the research definition of long Covid at 24 months, compared to males.
However, the researchers note that they did not assess menstruation and some symptoms (such as headaches and tiredness) may be attributable to pre-menstrual syndrome given the high proportion of girls.
Study Chief Investigator and first author, Professor Sir Terence Stephenson, said: "Our findings show that for teenagers who fulfilled our research definition of long Covid three months after a positive test for the Covid virus, the majority have recovered after two years. This is good news but we intend to do further research to try to better understand why 68 teenagers had not recovered."
The CLoCK study is a major study funded by the National Institute for Health and Care Research (NIHR) and UK Research and Innovation (UKRI) to help improve understanding of the causes, symptoms, and treatment of the longer-term effects of Covid-19 in people who have not become unwell enough to be admitted to hospital.
The study was co-led by the UK Health Security Agency (UKHSA) in collaboration with researchers at Great Ormond Street Hospital for Children NHS Foundation Trust (GOSH), Imperial College London, King's College London, Manchester University NHS Foundation Trust, the Universities of Bristol, Cambridge, Edinburgh, Liverpool, Manchester and Oxford, and University College London Hospitals NHS Foundation Trust. CLoCK also works closely with a patient and public involvement advisory group.
Following the 24-month results, data from all time points are now publicly available to other researchers.
The UCL researchers recently published a commentary, alongside colleagues at GOSH and the University of Brighton, on why better collaboration is needed between clinicians, interventionalists, epidemiologists, statisticians and those with lived experience to ensure a more effective, coordinated response ahead of future pandemics.
Study limitations
The symptoms reported by participants at the time of testing are subject to recall bias as they were reported at the time of first contact with the CLoCK study. However, three-month, six-month, 12-month, and 24-month symptoms were reported at the time they were being experienced.
Of the 31,012 children and young people invited to fill in a questionnaire 24-months post-PCR test, 12,632 of them participated and so this is a self-selected group which may introduce bias in the results.
Original PCR tests were taken before the Delta and Omicron variants became dominant, so the findings may not reflect the long-term effects of these variants.
Children and young people self-reported their symptoms. In some instances, such as to assess shortness of breath, it may have been better to conduct in-person medical interviews. However, this was not feasible or practical during the study period.
Importantly, the study primarily focuses on children and young people in England, and the findings may not be directly applicable to other populations or countries with different healthcare systems, vaccination rates, and demographics.
Reference: "A 24-month National Cohort Study examining long-term effects of COVID-19 in children and young people" by Terence Stephenson, Snehal M. Pinto Pereira, Manjula D. Nugawela, Emma Dalrymple, Anthony Harnden, Elizabeth Whittaker, Isobel Heyman, Tamsin Ford, Terry Segal, Trudie Chalder, Shamez N. Ladhani, Kelsey McOwat, Ruth Simmons, Laila Xu, Lana Fox-Smith, CLoCk Consortium and Roz Shafran, 4 December 2024, Communications Medicine.
DOI: 10.1038/s43856-024-00657-x
News
Researchers Solve the Mystery Behind a Billion-Dollar Dental Implant Disease
Researchers have uncovered why a common and costly dental implant infection often resists antibiotics. Dental implants have helped tens of millions of people regain a full set of stable, functional teeth, something traditional dentures [...]
Nanoparticles inspired by lung fluid improve therapies targeting respiratory system
The CIC biomaGUNE Center for Cooperative Research in Biomaterials has developed pulmonary surfactant nanoparticles (the blend of lipids and proteins that line the alveoli and enables breathing), which are encapsulated [...]
Scientists Finally Uncover How a “Forever Chemical” Causes Birth Defects
PFDA, a PFAS “forever chemical,” can cause craniofacial birth defects by disrupting retinoic acid regulation during fetal development, revealing the first clear molecular mechanism behind the link. Researchers have long linked perfluoroalkyl and polyfluoroalkyl substances (PFAS), [...]
Scientists Have Discovered These Deadly Parasites Are Secretly Swapping DNA
Leishmania parasites appear to evolve through widespread genetic exchange, reshaping assumptions about how they adapt and spread. A parasite long thought to spread mostly by cloning itself may be far more genetically dynamic than [...]
Stanford’s Revolutionary New Microscope Reveals Living Cells in Stunning Detail
Stanford researchers have developed a microscope that can show how nanostructures interact inside living cells at the highest resolution achieved so far. The view into living cells just got better. Stanford researchers have merged [...]
What Bundibugyo Ebola vaccines and treatments are under development
By Mariam Sunny and Jennifer Rigby May 29 (Reuters) – Global health authorities are racing to identify medical options to help contain an Ebola outbreak in eastern Democratic Republic of Congo, linked to the [...]
Why More People in Their 30s Are Suddenly Getting Colon Cancer
A major Swiss study found that colorectal cancer is becoming increasingly common in adults under 50, even as rates decline in older age groups. Researchers in Switzerland have identified a concerning trend: while colorectal [...]
Researchers Compare MS Models to Human Tissue in Search for Better Therapies
Researchers identified key differences between two widely used multiple sclerosis models, showing how each can better study myelin damage, immune responses, and repair. The findings may improve efforts to develop treatments that restore lost [...]
Scientists Discover Genetic “Off Switch” That Supercharges CAR T Cells Against Cancer
A new study reveals a possible way to make CAR T-cell therapy more durable and effective by targeting a single gene-regulating protein. CAR T-cell therapy is widely seen as a breakthrough in personalized cancer [...]
New Vitamin B12-Based Therapy Could Change How Brain Cancer Is Treated
Researchers have identified a vitamin B12–based compound that appears capable of crossing the blood–brain barrier and selectively accumulating in glioblastoma tissue. For decades, one of the biggest problems in brain cancer treatment has had [...]
Simple Fiber Supplement Cuts Knee Arthritis Pain in Just 6 Weeks, Study Finds
A daily inulin supplement may help reduce knee osteoarthritis pain while revealing a possible link between gut health, muscle function, and pain sensitivity. For millions of people living with knee osteoarthritis, managing chronic pain [...]
This Common Vitamin May Help Stop Prediabetes From Turning Into Diabetes
Vitamin D may help prevent type 2 diabetes in people with specific genetic variations, offering a possible path toward personalized diabetes prevention. More than 40% of U.S. adults have prediabetes, a condition in which [...]
Ebola, hantavirus: Is the world prepared for the next pandemic?
Funding cuts to health research and a growing antivaccine movement are making it harder than ever to respond to viruses. The World Health Organization (WHO) has declared that an Ebola outbreak in Uganda and [...]
May 2026 Healthcare News and Trends: Market Signals That Matter
Artificial intelligence is dominating headlines, telehealth has settled into a new normal, and digital health continues to promise transformation. However, much of what is being discussed in healthcare today reflects potential rather than reality. [...]
Scientists Rewire Donor Stem Cells To Outsmart Aggressive Blood Cancers
Researchers have tested a gene-edited stem cell transplant designed to shield healthy blood-forming cells from powerful cancer-targeting immunotherapies. For patients with highly aggressive blood cancers, stem cell transplantation can offer a rare chance at [...]
Recent Digital Health Trends, Insights and News – May 2026
Last month marked continued progress as digital health moves into its next phase — from AI expanding into drug discovery and core infrastructure to new federal pathways accelerating device access and home-based care. Together, [...]















